Back
XENE long @ 38.31

Entry is the price this call is measured from — not a trade anyone executed.

30.95 39.76 48.58 57.39 66.21 Aug 27 Sep 14 Sep 29 Oct 14 Oct 29 apesalpha.com TRADED Sep 30 ENTRY 38.31
Entry 38.31 At close 37.54 -2.0% vs entry 21 sessions since the post 2026-08-27 → 2026-10-29 traded Sep 30, filed later

2 different insiders at Xenon Pharmaceuticals Inc. just bought XENE.

  1. The cluster: 2 people, $1,681,140 between them in the last 30 days, each paying their own price separately.
  2. The biggest buy: Ian Mortimer (PRESIDENT & CEO), 30,000 shares at $37.38 on 30 September 2026. That is the entry above -- a Form 4 discloses the price actually paid, so this is a real fill, not an estimate. It is what they paid on their own trade date, though, not a price available now.

Also buying: Thomas Patrick Kelly (Chief Financial Officer, $559,740).
3. Filed: 1 October 2026.

Risk: several different people buying is the whole signal -- one person buying repeatedly is one decision. Grants, option exercises and tax withholdings are excluded, since none of those is anybody choosing to put money in. An automated tracker of public SEC filings, not a recommendation.

· Thu, 01 Oct · · 10 views 6 clicks

0 comments

No comments yet.

You’re posting as a guest. Sign in to post under your own name.